ABOUT US
OUROBIONICS STORY
Ourobionics is a deep technology company active in the field of 4D Bioprinting. It was founded in March 2021 by a group of business and academic experts. It focuses on the development and production of realistic human tissues embedded with biosensors, bioelectronics and or therapeutic agents. These applications can be used by pharmaceutical and med-tech companies to get a better understanding of diseases as well as for the development of new treatments, safety testing, efficacy testing and further improvement of existing treatments.
​
We utilize our own development biofabrication platform called CHIMERA which will allow the deposition of multiple biomaterials in any composition in gradient to create diversity in the 3D tissue. It utilizes “electric field” technologies which compared to others are recognized in many publications for their superiority in keeping cells alive and functional which is essential to make realistic tissue.
By using these tissues for testing compared to the regular animal testing it will allow for a faster time to market, better translational value, less ethical problems and better treatments.
MEET OUR TEAM
MEET THE MINDS
BEHIND OUROBIONICS
Ourobionics team brings business and industry experts together with academic experts. Together we have 50+ years of combined experience in research and corporate environment.
JOHN
ZANDBERGEN
​CHIEF EXECUTIVE OFFICER
John is an entrepreneur with 20+ years of international business experience. He has held sales and marketing leading positions with several companies before starting his own consultancy company
PROF. SUWAN N.
JAYASINGHE
CHIEF SCIENTIFIC OFFICER
Suwan N. Jayasinghe leads the BioPhysics Group at University College London. Jayasinghe’s group has published over 150 scientific articles, which have been highlighted in many learned society journals.
ASS. PROF. ALIREZA PIROUZ
CHIEF TECHNOLOGY OFFICER
Dr. Alireza Dolatshahi-Pirouz is working at DTU Nanotech, Denmark. He is developing new 3D environments for directing stem cells into tissue-like structures and self-healable and stretchable materials with high electrical sensitivity.
PROF. ALVARO
MATA
CHIEF INNOVATION OFFICER
Alvaro Mata is the Chair in Biomedical Engineering & Biomaterials, Faculty of Science in the University of Nottingham research aims to integrate supramolecular chemistry with engineering principles to develop creative and innovative ways to use biomolecules to build intelligent and functional biomedical devices
DR. STEPHEN
G. GRAY
CO-FOUNDER
Stephen is a serial entrepreneur with over 10 years of building in management roles and advising companies in the sector of 3D Bioprinting and Regenerative Medicine. His background is in biomedical engineering from Imperial College London .
Dr. DORIS
ZORIC
CHIEF MARKETING OFFICER
Doris is a Ph.D. graduate in structural biology at the University of Gothenburg. She has a strong marketing and design skillset and experience in assisting early-stage startup ventures such as Gutsbv and Orgonex in brand, content, website design and brochures